Wang Chang-yi

A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. See our advice if the article is about you and read our scam warning in case someone asks for money to edit this article. (October 2019) (Learn how and when to remove this message)

Wang Chang-yi
王長怡
Born	(1951-12-19) December 19, 1951 (age 74) Taipei, Taiwan
Education	National Taiwan University (BS) Rockefeller University (PhD)
Known for	Synthetic peptide based immunological applications in diagnostics, vaccines and immunotherapeutics. Protein drugs including innovative monoclonal antibodies and long acting protein drugs.
Scientific career
Fields	Biochemistry Immunology
Workplaces	Memorial Sloan Kettering Cancer Center
Thesis	Structural and Functional Characterication of Surface Antigens on Human B Lymphocytes  (1979)
Doctoral advisor	Henry Kunkel
Other academic advisors	Robert Bruce Merrifield Ralph M. Steinman
Chinese name
Traditional Chinese	王長怡
Simplified Chinese	王长怡
Transcriptions Standard Mandarin Hanyu Pinyin Wángzhǎngyí IPA [tʃɒ̌ŋ jí wɒ́ŋ]

Wang Chang-yi (Chinese: 王長怡; pinyin: Wáng Zhǎngyí; born December 19, 1951) is a Taiwanese biochemist and immunologist. She is the founder of United Biomedical, Inc. [zh] (UBI), headquartered in Hauppauge, New York, and its group of companies in Asia.

Early life and education

Wang was born in Taiwan in 1951. Her father was a member of the National Assembly. She was inspired by physicist Chien-Shiung Wu, who disproved the ‘conservation of parity’ theory in 1957, to go into science. She graduated with honors from National Taiwan University with a bachelor's degree in organic chemistry in 1973.

After graduating from National Taiwan University, Chang completed graduate studies in the United States at Rockefeller University, where she was the first Asian woman in its graduate program. She earned her Ph.D. in 1979 with a dual specialization in biochemistry and immunology. As a graduate student, she was mentored by Bruce Merrifield, Henry Kunkel, Gerald Edelman and Ralph Steinman. She then joined the Memorial Sloan Kettering Cancer Center as the youngest faculty member, principal investigator, and head of the molecular immunology laboratory.

Career

In 1985, Wang and her husband Nean Hu founded United Biomedical, Inc. in New York, a company focusing on medicine and vaccine development. She founded United Biomedical, Inc. Asia in Taiwan in 1998. She later founded United Biopharma and UBI Pharma in 2013 and 2014 respectively. The companies later created testing for HIV and Hepatitis C, and carried out research on a vaccine for HIV.

Wang is the author of more than 120 peer-reviewed scientific publications and by 2019, she was the inventor of more than 80 patents.

Family

Wang’s daughter, Mei Mei Hu, is the co-founder and CEO of Vaxxinity (originally named Covaxx), a subsidiary of UBI. Vaxxinityoriginally focused on possible vaccines for Alzheimer’s and animal health, but shifted to working on a vaccine for COVID-19. The company helped to develop vaccine candidate UB-612.

Professional and honorary affiliations

• National Institutes of Health, United States
• National Taiwan University (Adjunct Professor)
• National Tsing Hua University (Adjunct Professor)

References

External links

• United Biomedical, Official site